We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

181 hedge funds and large institutions have $1.11B invested in Arcus Biosciences in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 65 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more call options, than puts

Call options by funds: $26.7M | Put options by funds: $23.2M

13% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 23

10% more capital invested

Capital invested by funds: $1.01B → $1.11B (+$98.2M)

1% more funds holding

Funds holding: 179 → 181 (+2)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

9% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 65

1.11% less ownership

Funds ownership: 75.93% → 74.82% (-1.1%)

Holders
181
Holders Change
+2
Holders Change %
+1.12%
% of All Funds
2.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
26
Increased
59
Reduced
65
Closed
23
Calls
$26.7M
Puts
$23.2M
Net Calls
+$3.5M
Net Calls Change
+$742K

Top Buyers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$35.5M
2
Ameriprise
Ameriprise
Minnesota
+$24.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.8M
4
LGM
Logos Global Management
California
+$14.3M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$13.5M

Top Sellers

1
State Street
State Street
Massachusetts
-$22M
2
Citadel Advisors
Citadel Advisors
Florida
-$19.6M
3
Bank of America
Bank of America
North Carolina
-$18.3M
4
BlackRock
BlackRock
New York
-$12.7M
5
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
76
Algert Global
California
$1.26M -$1.03M -53,901 -46%
Massachusetts Financial Services
77
Massachusetts Financial Services
Massachusetts
$1.23M -$27.1K -1,422 -2%
COPPSERS
78
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.21M +$81.8K +4,298 +8%
PA
79
Profund Advisors
Maryland
$1.15M -$407K -21,376 -27%
CS
80
Credit Suisse
Switzerland
$1.14M +$410K +21,555 +62%
California State Teachers Retirement System (CalSTRS)
81
California State Teachers Retirement System (CalSTRS)
California
$1.14M -$22.3K -1,172 -2%
KWILP
82
Kiwi Wealth Investments Limited Partnership
New Zealand
$1.13M – – –
Millennium Management
83
Millennium Management
New York
$1.12M +$1.05M +55,345 New
AA
84
ALPS Advisors
Colorado
$1.09M +$107K +5,637 +12%
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.04M +$15.7K +822 +2%
Thrivent Financial for Lutherans
86
Thrivent Financial for Lutherans
Minnesota
$1.02M -$25K -1,312 -3%
JAM
87
Jupiter Asset Management
United Kingdom
$986K +$121K +6,333 +15%
TPSF
88
Texas Permanent School Fund
Texas
$941K -$8.15K -428 -0.9%
Canada Life
89
Canada Life
Manitoba, Canada
$924K -$61.7K -3,239 -7%
VRS
90
Virginia Retirement Systems
Virginia
$816K -$354K -18,600 -32%
MCM
91
Moore Capital Management
New York
$812K +$762K +40,000 New
Federated Hermes
92
Federated Hermes
Pennsylvania
$800K +$665K +34,915 +784%
Two Sigma Advisers
93
Two Sigma Advisers
New York
$764K -$1.48M -77,800 -67%
Allianz Asset Management
94
Allianz Asset Management
Germany
$756K -$636K -33,400 -47%
State of Wisconsin Investment Board
95
State of Wisconsin Investment Board
Wisconsin
$752K -$38.3K -2,013 -5%
New York State Common Retirement Fund
96
New York State Common Retirement Fund
New York
$733K -$254K -13,347 -27%
CAM
97
Cresset Asset Management
Illinois
$714K +$669K +35,133 New
CC
98
Centiva Capital
New York
$711K +$666K +34,984 New
SOADOR
99
State of Alaska Department of Revenue
Alaska
$703K -$20.3K -1,066 -3%
TCM
100
Tekla Capital Management
Massachusetts
$667K – – –
2 3
4
5 6

RCUS Hedge Fund Activity: Q2 2023 in Review

181 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q2 2023, worth a combined $1.11B — up 9.7% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RCUS positions and 23 closed out — a net gain of 3 holders — while 59 added to existing stakes and 65 trimmed.

The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $35.5M. The largest seller was State Street, cutting an estimated $22M.

  • 181 institutional investors held Arcus Biosciences (RCUS) as of Q2 2023, up from 179 in Q1 2023.
  • Funds reported $1.11B of Arcus Biosciences stock for Q2 2023, up 9.7% quarter-over-quarter.
  • 26 funds opened new Arcus Biosciences positions in Q2 2023 and 23 closed out, a net change of +3 holders.
  • The largest Arcus Biosciences buyer in Q2 2023 was Balyasny Asset Management, an estimated $35.5M added.
  • The largest Arcus Biosciences seller in Q2 2023 was State Street, an estimated $22M sold.

Based on aggregated 13F filings for Q2 2023.